DMD and Becker muscular dystrophy: A previous report demonstrated that a deletion of exons 3–9 was associated with an asymptomatic phenotype at the age of 27, indicating that multiexon skipping therapy might become a therapeutic option for patients not only with DMD but also with BMD accompanied with severe cardiac dysfunction [24].